• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Louisiana bill seeks closed formulary

News
Article

A Louisiana senator is calling for a closed drug formulary for the state’s Worker’s Compensation program, to help combat the overutilization of opioids and compounded drugs.

A Louisiana senator is calling for a closed drug formulary for the state’s worker’s compensation program, to help combat the overutilization of opioids and compounded drugs.

Related: HIV/AIDs drugs reclassified at Aetna, Coventry in Florida

Sen. Danny Martiny (Rep.) filed S.B. 256, which says the state should switch to a closed formulary. The bill also says the Office of Worker’s Compensation should set up a Closed Formulary Oversight Panel made up of pharmacists and physicians.

Closed formularies, which have reduced workers comp medical costs in Ohio, Texas and Washington, require proof that non-formulary medications - or “N” drugs - are medically necessary before they can be prescribed to injured workers, according to an article in Business Insurance. A limited list of covered medications - or “Y” drugs - don’t require preauthorization.

Related: [BLOG]: Best Practices between formulary managers and pharmacits to address challenges in COPD readmissions

According to the bill, "N" drugs would include medications labeled narcotics by FDA, any compounded drugs or compound medication, any experimental drugs and any drugs that aren’t listed on the closed formulary at the time of prescription.

The closed formulary won’t apply to claims with a date of injury prior to Jan. 1, 2016, according to S.B. 256.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.